Christopher Whaley is a Policy Researcher at the RAND Corporation. Read Bio
The goal of the study is to examine if consumer-directed health plans (CDHPs) and other forms of consumer-directed health care are effective policies or if they lead to high patient costs with little impact on value. Using data from the Health Care Cost Institute (HCCI), the researchers will examine the effect of increased market-level exposure to consumer-directed health plans (CDHPs) on provider prices for common health care services. They will test three hypotheses: (1) increased CDHP penetration in a given market will lead to lower prices for shoppable services in that market; (2) increased CDHP penetration in a given market will lead to larger price reductions for more expensive providers and for more shoppable commoditized services; and (3) increased CDHP penetration in a given market will lead to lesser variation in provider prices within that market. Deliverables will include a project work plan and final narrative report. The researchers will also produce paper(s) suitable for publication and present findings at national research meetings and to other stakeholder audiences as appropriate, including policymakers at the federal, state, and local levels and other key stakeholders, as part of the deliverables for this grant.
Grantee Institution: RAND Corporation
Grant Period: 9/15/19 – 9/14/20